PATENT CLAIM ANALYSIS

Application Number: 15911543
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "575000"]

Abstract:
One aspect of the present invention relates to a method of treating or preventing pathologic sequelae of acute hyperglycemia and/or increased fatty acid flux in a subject. This method involves administering an ROS inhibitor to the subject. In addition, methods of promoting neovascularization, inhibiting oxidation or excessive release of free fatty acids, and identifying compounds suitable for treatment or prevention of ROS-mediated injury are also disclosed.

Claim (Index 8):
The method of  claim 7  wherein DFO is injected subcutaneously.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.30909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11297808', '11136254', '15623898', '14299570', '15089937']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8183665263159788
- 35 USC 102 Novelty (BERT): 0.5870135398891371
- Combined Prediction Score: 0.7952312276732947
- Mean Citation Score: 414.145394
- Max Citation Score: 609.57117
- Similarity Product: 386.7674373180754

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test